Global Rabies Immune Globulin (Equine) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Rabies Immune Globulin (Equine) market size was valued at USD 1234.7 million in 2022 and is forecast to a readjusted size of USD 1555 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
This report is a detailed and comprehensive analysis for global Rabies Immune Globulin (Equine) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rabies Immune Globulin (Equine) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Equine) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Equine) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Equine) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Immune Globulin (Equine)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Immune Globulin (Equine) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, Serum China, Premium Serums, Intas and Aventis Pasteur India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Rabies Immune Globulin (Equine) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Rabies Immune Globulin (Equine) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Immune Globulin (Equine), with price, sales, revenue and global market share of Rabies Immune Globulin (Equine) from 2018 to 2023.
Chapter 3, the Rabies Immune Globulin (Equine) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Immune Globulin (Equine) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rabies Immune Globulin (Equine) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Immune Globulin (Equine).
Chapter 14 and 15, to describe Rabies Immune Globulin (Equine) sales channel, distributors, customers, research findings and conclusion.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
This report is a detailed and comprehensive analysis for global Rabies Immune Globulin (Equine) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rabies Immune Globulin (Equine) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Equine) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Equine) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabies Immune Globulin (Equine) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Immune Globulin (Equine)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Immune Globulin (Equine) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, Serum China, Premium Serums, Intas and Aventis Pasteur India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Rabies Immune Globulin (Equine) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 1500IU
- 1000IU
- 400IU
- Others
- Clinic
- Hospital
- Grifols
- Serum China
- Premium Serums
- Intas
- Aventis Pasteur India
- Cadila Pharmaceuticals
- Zydus Takeda Healthcare
- Bharat Serums And Vaccines
- GlaxoSmithKline GmbH
- VINS Bioproducts
- CSL Behring
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rabies Immune Globulin (Equine) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Immune Globulin (Equine), with price, sales, revenue and global market share of Rabies Immune Globulin (Equine) from 2018 to 2023.
Chapter 3, the Rabies Immune Globulin (Equine) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Immune Globulin (Equine) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rabies Immune Globulin (Equine) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Immune Globulin (Equine).
Chapter 14 and 15, to describe Rabies Immune Globulin (Equine) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rabies Immune Globulin (Equine)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Immune Globulin (Equine) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 1500IU
1.3.3 1000IU
1.3.4 400IU
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Immune Globulin (Equine) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.5 Global Rabies Immune Globulin (Equine) Market Size & Forecast
1.5.1 Global Rabies Immune Globulin (Equine) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rabies Immune Globulin (Equine) Sales Quantity (2018-2029)
1.5.3 Global Rabies Immune Globulin (Equine) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Rabies Immune Globulin (Equine) Product and Services
2.1.4 Grifols Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Grifols Recent Developments/Updates
2.2 Serum China
2.2.1 Serum China Details
2.2.2 Serum China Major Business
2.2.3 Serum China Rabies Immune Globulin (Equine) Product and Services
2.2.4 Serum China Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Serum China Recent Developments/Updates
2.3 Premium Serums
2.3.1 Premium Serums Details
2.3.2 Premium Serums Major Business
2.3.3 Premium Serums Rabies Immune Globulin (Equine) Product and Services
2.3.4 Premium Serums Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Premium Serums Recent Developments/Updates
2.4 Intas
2.4.1 Intas Details
2.4.2 Intas Major Business
2.4.3 Intas Rabies Immune Globulin (Equine) Product and Services
2.4.4 Intas Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intas Recent Developments/Updates
2.5 Aventis Pasteur India
2.5.1 Aventis Pasteur India Details
2.5.2 Aventis Pasteur India Major Business
2.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Product and Services
2.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aventis Pasteur India Recent Developments/Updates
2.6 Cadila Pharmaceuticals
2.6.1 Cadila Pharmaceuticals Details
2.6.2 Cadila Pharmaceuticals Major Business
2.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product and Services
2.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cadila Pharmaceuticals Recent Developments/Updates
2.7 Zydus Takeda Healthcare
2.7.1 Zydus Takeda Healthcare Details
2.7.2 Zydus Takeda Healthcare Major Business
2.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product and Services
2.7.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zydus Takeda Healthcare Recent Developments/Updates
2.8 Bharat Serums And Vaccines
2.8.1 Bharat Serums And Vaccines Details
2.8.2 Bharat Serums And Vaccines Major Business
2.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product and Services
2.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bharat Serums And Vaccines Recent Developments/Updates
2.9 GlaxoSmithKline GmbH
2.9.1 GlaxoSmithKline GmbH Details
2.9.2 GlaxoSmithKline GmbH Major Business
2.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product and Services
2.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GlaxoSmithKline GmbH Recent Developments/Updates
2.10 VINS Bioproducts
2.10.1 VINS Bioproducts Details
2.10.2 VINS Bioproducts Major Business
2.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Product and Services
2.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 VINS Bioproducts Recent Developments/Updates
2.11 CSL Behring
2.11.1 CSL Behring Details
2.11.2 CSL Behring Major Business
2.11.3 CSL Behring Rabies Immune Globulin (Equine) Product and Services
2.11.4 CSL Behring Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CSL Behring Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABIES IMMUNE GLOBULIN (EQUINE) BY MANUFACTURER
3.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rabies Immune Globulin (Equine) Revenue by Manufacturer (2018-2023)
3.3 Global Rabies Immune Globulin (Equine) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rabies Immune Globulin (Equine) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rabies Immune Globulin (Equine) Manufacturer Market Share in 2022
3.4.2 Top 6 Rabies Immune Globulin (Equine) Manufacturer Market Share in 2022
3.5 Rabies Immune Globulin (Equine) Market: Overall Company Footprint Analysis
3.5.1 Rabies Immune Globulin (Equine) Market: Region Footprint
3.5.2 Rabies Immune Globulin (Equine) Market: Company Product Type Footprint
3.5.3 Rabies Immune Globulin (Equine) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rabies Immune Globulin (Equine) Market Size by Region
4.1.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2029)
4.1.2 Global Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2029)
4.1.3 Global Rabies Immune Globulin (Equine) Average Price by Region (2018-2029)
4.2 North America Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.3 Europe Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.4 Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.5 South America Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.6 Middle East and Africa Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
5.2 Global Rabies Immune Globulin (Equine) Consumption Value by Type (2018-2029)
5.3 Global Rabies Immune Globulin (Equine) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
6.2 Global Rabies Immune Globulin (Equine) Consumption Value by Application (2018-2029)
6.3 Global Rabies Immune Globulin (Equine) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
7.2 North America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
7.3 North America Rabies Immune Globulin (Equine) Market Size by Country
7.3.1 North America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
7.3.2 North America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
8.2 Europe Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
8.3 Europe Rabies Immune Globulin (Equine) Market Size by Country
8.3.1 Europe Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
8.3.2 Europe Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rabies Immune Globulin (Equine) Market Size by Region
9.3.1 Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
10.2 South America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
10.3 South America Rabies Immune Globulin (Equine) Market Size by Country
10.3.1 South America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
10.3.2 South America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rabies Immune Globulin (Equine) Market Size by Country
11.3.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Rabies Immune Globulin (Equine) Market Drivers
12.2 Rabies Immune Globulin (Equine) Market Restraints
12.3 Rabies Immune Globulin (Equine) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rabies Immune Globulin (Equine) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Immune Globulin (Equine)
13.3 Rabies Immune Globulin (Equine) Production Process
13.4 Rabies Immune Globulin (Equine) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Immune Globulin (Equine) Typical Distributors
14.3 Rabies Immune Globulin (Equine) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rabies Immune Globulin (Equine)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Immune Globulin (Equine) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 1500IU
1.3.3 1000IU
1.3.4 400IU
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Immune Globulin (Equine) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.5 Global Rabies Immune Globulin (Equine) Market Size & Forecast
1.5.1 Global Rabies Immune Globulin (Equine) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rabies Immune Globulin (Equine) Sales Quantity (2018-2029)
1.5.3 Global Rabies Immune Globulin (Equine) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Rabies Immune Globulin (Equine) Product and Services
2.1.4 Grifols Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Grifols Recent Developments/Updates
2.2 Serum China
2.2.1 Serum China Details
2.2.2 Serum China Major Business
2.2.3 Serum China Rabies Immune Globulin (Equine) Product and Services
2.2.4 Serum China Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Serum China Recent Developments/Updates
2.3 Premium Serums
2.3.1 Premium Serums Details
2.3.2 Premium Serums Major Business
2.3.3 Premium Serums Rabies Immune Globulin (Equine) Product and Services
2.3.4 Premium Serums Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Premium Serums Recent Developments/Updates
2.4 Intas
2.4.1 Intas Details
2.4.2 Intas Major Business
2.4.3 Intas Rabies Immune Globulin (Equine) Product and Services
2.4.4 Intas Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intas Recent Developments/Updates
2.5 Aventis Pasteur India
2.5.1 Aventis Pasteur India Details
2.5.2 Aventis Pasteur India Major Business
2.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Product and Services
2.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aventis Pasteur India Recent Developments/Updates
2.6 Cadila Pharmaceuticals
2.6.1 Cadila Pharmaceuticals Details
2.6.2 Cadila Pharmaceuticals Major Business
2.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product and Services
2.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cadila Pharmaceuticals Recent Developments/Updates
2.7 Zydus Takeda Healthcare
2.7.1 Zydus Takeda Healthcare Details
2.7.2 Zydus Takeda Healthcare Major Business
2.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product and Services
2.7.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zydus Takeda Healthcare Recent Developments/Updates
2.8 Bharat Serums And Vaccines
2.8.1 Bharat Serums And Vaccines Details
2.8.2 Bharat Serums And Vaccines Major Business
2.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product and Services
2.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bharat Serums And Vaccines Recent Developments/Updates
2.9 GlaxoSmithKline GmbH
2.9.1 GlaxoSmithKline GmbH Details
2.9.2 GlaxoSmithKline GmbH Major Business
2.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product and Services
2.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GlaxoSmithKline GmbH Recent Developments/Updates
2.10 VINS Bioproducts
2.10.1 VINS Bioproducts Details
2.10.2 VINS Bioproducts Major Business
2.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Product and Services
2.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 VINS Bioproducts Recent Developments/Updates
2.11 CSL Behring
2.11.1 CSL Behring Details
2.11.2 CSL Behring Major Business
2.11.3 CSL Behring Rabies Immune Globulin (Equine) Product and Services
2.11.4 CSL Behring Rabies Immune Globulin (Equine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CSL Behring Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABIES IMMUNE GLOBULIN (EQUINE) BY MANUFACTURER
3.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rabies Immune Globulin (Equine) Revenue by Manufacturer (2018-2023)
3.3 Global Rabies Immune Globulin (Equine) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rabies Immune Globulin (Equine) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rabies Immune Globulin (Equine) Manufacturer Market Share in 2022
3.4.2 Top 6 Rabies Immune Globulin (Equine) Manufacturer Market Share in 2022
3.5 Rabies Immune Globulin (Equine) Market: Overall Company Footprint Analysis
3.5.1 Rabies Immune Globulin (Equine) Market: Region Footprint
3.5.2 Rabies Immune Globulin (Equine) Market: Company Product Type Footprint
3.5.3 Rabies Immune Globulin (Equine) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rabies Immune Globulin (Equine) Market Size by Region
4.1.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2029)
4.1.2 Global Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2029)
4.1.3 Global Rabies Immune Globulin (Equine) Average Price by Region (2018-2029)
4.2 North America Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.3 Europe Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.4 Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.5 South America Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
4.6 Middle East and Africa Rabies Immune Globulin (Equine) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
5.2 Global Rabies Immune Globulin (Equine) Consumption Value by Type (2018-2029)
5.3 Global Rabies Immune Globulin (Equine) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
6.2 Global Rabies Immune Globulin (Equine) Consumption Value by Application (2018-2029)
6.3 Global Rabies Immune Globulin (Equine) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
7.2 North America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
7.3 North America Rabies Immune Globulin (Equine) Market Size by Country
7.3.1 North America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
7.3.2 North America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
8.2 Europe Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
8.3 Europe Rabies Immune Globulin (Equine) Market Size by Country
8.3.1 Europe Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
8.3.2 Europe Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rabies Immune Globulin (Equine) Market Size by Region
9.3.1 Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
10.2 South America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
10.3 South America Rabies Immune Globulin (Equine) Market Size by Country
10.3.1 South America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
10.3.2 South America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rabies Immune Globulin (Equine) Market Size by Country
11.3.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Rabies Immune Globulin (Equine) Market Drivers
12.2 Rabies Immune Globulin (Equine) Market Restraints
12.3 Rabies Immune Globulin (Equine) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rabies Immune Globulin (Equine) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Immune Globulin (Equine)
13.3 Rabies Immune Globulin (Equine) Production Process
13.4 Rabies Immune Globulin (Equine) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Immune Globulin (Equine) Typical Distributors
14.3 Rabies Immune Globulin (Equine) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rabies Immune Globulin (Equine) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rabies Immune Globulin (Equine) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Rabies Immune Globulin (Equine) Product and Services
Table 6. Grifols Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Grifols Recent Developments/Updates
Table 8. Serum China Basic Information, Manufacturing Base and Competitors
Table 9. Serum China Major Business
Table 10. Serum China Rabies Immune Globulin (Equine) Product and Services
Table 11. Serum China Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Serum China Recent Developments/Updates
Table 13. Premium Serums Basic Information, Manufacturing Base and Competitors
Table 14. Premium Serums Major Business
Table 15. Premium Serums Rabies Immune Globulin (Equine) Product and Services
Table 16. Premium Serums Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Premium Serums Recent Developments/Updates
Table 18. Intas Basic Information, Manufacturing Base and Competitors
Table 19. Intas Major Business
Table 20. Intas Rabies Immune Globulin (Equine) Product and Services
Table 21. Intas Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Intas Recent Developments/Updates
Table 23. Aventis Pasteur India Basic Information, Manufacturing Base and Competitors
Table 24. Aventis Pasteur India Major Business
Table 25. Aventis Pasteur India Rabies Immune Globulin (Equine) Product and Services
Table 26. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Aventis Pasteur India Recent Developments/Updates
Table 28. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Cadila Pharmaceuticals Major Business
Table 30. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product and Services
Table 31. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cadila Pharmaceuticals Recent Developments/Updates
Table 33. Zydus Takeda Healthcare Basic Information, Manufacturing Base and Competitors
Table 34. Zydus Takeda Healthcare Major Business
Table 35. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product and Services
Table 36. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zydus Takeda Healthcare Recent Developments/Updates
Table 38. Bharat Serums And Vaccines Basic Information, Manufacturing Base and Competitors
Table 39. Bharat Serums And Vaccines Major Business
Table 40. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product and Services
Table 41. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bharat Serums And Vaccines Recent Developments/Updates
Table 43. GlaxoSmithKline GmbH Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline GmbH Major Business
Table 45. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product and Services
Table 46. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GlaxoSmithKline GmbH Recent Developments/Updates
Table 48. VINS Bioproducts Basic Information, Manufacturing Base and Competitors
Table 49. VINS Bioproducts Major Business
Table 50. VINS Bioproducts Rabies Immune Globulin (Equine) Product and Services
Table 51. VINS Bioproducts Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. VINS Bioproducts Recent Developments/Updates
Table 53. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 54. CSL Behring Major Business
Table 55. CSL Behring Rabies Immune Globulin (Equine) Product and Services
Table 56. CSL Behring Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CSL Behring Recent Developments/Updates
Table 58. Global Rabies Immune Globulin (Equine) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Rabies Immune Globulin (Equine) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Rabies Immune Globulin (Equine) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Rabies Immune Globulin (Equine), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Rabies Immune Globulin (Equine) Production Site of Key Manufacturer
Table 63. Rabies Immune Globulin (Equine) Market: Company Product Type Footprint
Table 64. Rabies Immune Globulin (Equine) Market: Company Product Application Footprint
Table 65. Rabies Immune Globulin (Equine) New Market Entrants and Barriers to Market Entry
Table 66. Rabies Immune Globulin (Equine) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Rabies Immune Globulin (Equine) Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Rabies Immune Globulin (Equine) Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Rabies Immune Globulin (Equine) Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Rabies Immune Globulin (Equine) Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Rabies Immune Globulin (Equine) Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Rabies Immune Globulin (Equine) Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Rabies Immune Globulin (Equine) Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Rabies Immune Globulin (Equine) Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Rabies Immune Globulin (Equine) Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Rabies Immune Globulin (Equine) Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Rabies Immune Globulin (Equine) Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Rabies Immune Globulin (Equine) Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Rabies Immune Globulin (Equine) Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Rabies Immune Globulin (Equine) Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Rabies Immune Globulin (Equine) Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Rabies Immune Globulin (Equine) Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Rabies Immune Globulin (Equine) Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Rabies Immune Globulin (Equine) Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Rabies Immune Globulin (Equine) Raw Material
Table 126. Key Manufacturers of Rabies Immune Globulin (Equine) Raw Materials
Table 127. Rabies Immune Globulin (Equine) Typical Distributors
Table 128. Rabies Immune Globulin (Equine) Typical Customers
Table 1. Global Rabies Immune Globulin (Equine) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rabies Immune Globulin (Equine) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Rabies Immune Globulin (Equine) Product and Services
Table 6. Grifols Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Grifols Recent Developments/Updates
Table 8. Serum China Basic Information, Manufacturing Base and Competitors
Table 9. Serum China Major Business
Table 10. Serum China Rabies Immune Globulin (Equine) Product and Services
Table 11. Serum China Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Serum China Recent Developments/Updates
Table 13. Premium Serums Basic Information, Manufacturing Base and Competitors
Table 14. Premium Serums Major Business
Table 15. Premium Serums Rabies Immune Globulin (Equine) Product and Services
Table 16. Premium Serums Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Premium Serums Recent Developments/Updates
Table 18. Intas Basic Information, Manufacturing Base and Competitors
Table 19. Intas Major Business
Table 20. Intas Rabies Immune Globulin (Equine) Product and Services
Table 21. Intas Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Intas Recent Developments/Updates
Table 23. Aventis Pasteur India Basic Information, Manufacturing Base and Competitors
Table 24. Aventis Pasteur India Major Business
Table 25. Aventis Pasteur India Rabies Immune Globulin (Equine) Product and Services
Table 26. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Aventis Pasteur India Recent Developments/Updates
Table 28. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Cadila Pharmaceuticals Major Business
Table 30. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product and Services
Table 31. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cadila Pharmaceuticals Recent Developments/Updates
Table 33. Zydus Takeda Healthcare Basic Information, Manufacturing Base and Competitors
Table 34. Zydus Takeda Healthcare Major Business
Table 35. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product and Services
Table 36. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zydus Takeda Healthcare Recent Developments/Updates
Table 38. Bharat Serums And Vaccines Basic Information, Manufacturing Base and Competitors
Table 39. Bharat Serums And Vaccines Major Business
Table 40. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product and Services
Table 41. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bharat Serums And Vaccines Recent Developments/Updates
Table 43. GlaxoSmithKline GmbH Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline GmbH Major Business
Table 45. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product and Services
Table 46. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GlaxoSmithKline GmbH Recent Developments/Updates
Table 48. VINS Bioproducts Basic Information, Manufacturing Base and Competitors
Table 49. VINS Bioproducts Major Business
Table 50. VINS Bioproducts Rabies Immune Globulin (Equine) Product and Services
Table 51. VINS Bioproducts Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. VINS Bioproducts Recent Developments/Updates
Table 53. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 54. CSL Behring Major Business
Table 55. CSL Behring Rabies Immune Globulin (Equine) Product and Services
Table 56. CSL Behring Rabies Immune Globulin (Equine) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CSL Behring Recent Developments/Updates
Table 58. Global Rabies Immune Globulin (Equine) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Rabies Immune Globulin (Equine) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Rabies Immune Globulin (Equine) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Rabies Immune Globulin (Equine), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Rabies Immune Globulin (Equine) Production Site of Key Manufacturer
Table 63. Rabies Immune Globulin (Equine) Market: Company Product Type Footprint
Table 64. Rabies Immune Globulin (Equine) Market: Company Product Application Footprint
Table 65. Rabies Immune Globulin (Equine) New Market Entrants and Barriers to Market Entry
Table 66. Rabies Immune Globulin (Equine) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Rabies Immune Globulin (Equine) Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Rabies Immune Globulin (Equine) Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Rabies Immune Globulin (Equine) Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Rabies Immune Globulin (Equine) Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Rabies Immune Globulin (Equine) Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Rabies Immune Globulin (Equine) Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Rabies Immune Globulin (Equine) Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Rabies Immune Globulin (Equine) Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Rabies Immune Globulin (Equine) Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Rabies Immune Globulin (Equine) Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Rabies Immune Globulin (Equine) Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Rabies Immune Globulin (Equine) Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Rabies Immune Globulin (Equine) Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Rabies Immune Globulin (Equine) Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Rabies Immune Globulin (Equine) Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Rabies Immune Globulin (Equine) Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Rabies Immune Globulin (Equine) Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Rabies Immune Globulin (Equine) Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Rabies Immune Globulin (Equine) Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Rabies Immune Globulin (Equine) Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Rabies Immune Globulin (Equine) Raw Material
Table 126. Key Manufacturers of Rabies Immune Globulin (Equine) Raw Materials
Table 127. Rabies Immune Globulin (Equine) Typical Distributors
Table 128. Rabies Immune Globulin (Equine) Typical Customers
LIST OF FIGURES
Figure 1. Rabies Immune Globulin (Equine) Picture
Figure 2. Global Rabies Immune Globulin (Equine) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Type in 2022
Figure 4. 1500IU Examples
Figure 5. 1000IU Examples
Figure 6. 400IU Examples
Figure 7. Others Examples
Figure 8. Global Rabies Immune Globulin (Equine) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Application in 2022
Figure 10. Clinic Examples
Figure 11. Hospital Examples
Figure 12. Global Rabies Immune Globulin (Equine) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Rabies Immune Globulin (Equine) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Rabies Immune Globulin (Equine) Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Rabies Immune Globulin (Equine) Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Rabies Immune Globulin (Equine) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Rabies Immune Globulin (Equine) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Rabies Immune Globulin (Equine) Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Rabies Immune Globulin (Equine) Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Rabies Immune Globulin (Equine) Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Rabies Immune Globulin (Equine) Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Rabies Immune Globulin (Equine) Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Rabies Immune Globulin (Equine) Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value Market Share by Region (2018-2029)
Figure 54. China Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Rabies Immune Globulin (Equine) Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Rabies Immune Globulin (Equine) Market Drivers
Figure 75. Rabies Immune Globulin (Equine) Market Restraints
Figure 76. Rabies Immune Globulin (Equine) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine) in 2022
Figure 79. Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
Figure 80. Rabies Immune Globulin (Equine) Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Rabies Immune Globulin (Equine) Picture
Figure 2. Global Rabies Immune Globulin (Equine) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Type in 2022
Figure 4. 1500IU Examples
Figure 5. 1000IU Examples
Figure 6. 400IU Examples
Figure 7. Others Examples
Figure 8. Global Rabies Immune Globulin (Equine) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Application in 2022
Figure 10. Clinic Examples
Figure 11. Hospital Examples
Figure 12. Global Rabies Immune Globulin (Equine) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Rabies Immune Globulin (Equine) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Rabies Immune Globulin (Equine) Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Rabies Immune Globulin (Equine) Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Rabies Immune Globulin (Equine) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Rabies Immune Globulin (Equine) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Rabies Immune Globulin (Equine) Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Rabies Immune Globulin (Equine) Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Rabies Immune Globulin (Equine) Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Rabies Immune Globulin (Equine) Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Rabies Immune Globulin (Equine) Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Rabies Immune Globulin (Equine) Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Rabies Immune Globulin (Equine) Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Rabies Immune Globulin (Equine) Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Rabies Immune Globulin (Equine) Consumption Value Market Share by Region (2018-2029)
Figure 54. China Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Rabies Immune Globulin (Equine) Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Rabies Immune Globulin (Equine) Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Rabies Immune Globulin (Equine) Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Rabies Immune Globulin (Equine) Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Rabies Immune Globulin (Equine) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Rabies Immune Globulin (Equine) Market Drivers
Figure 75. Rabies Immune Globulin (Equine) Market Restraints
Figure 76. Rabies Immune Globulin (Equine) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine) in 2022
Figure 79. Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
Figure 80. Rabies Immune Globulin (Equine) Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
